Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jul 15:16:1367-1378.
doi: 10.2147/CIA.S297494. eCollection 2021.

Diabetic Retinopathy in the Aging Population: A Perspective of Pathogenesis and Treatment

Sameer P Leley  1 , Thomas A Ciulla  2   3   4 , Ashay D Bhatwadekar  2
Affiliations
Review

Diabetic Retinopathy in the Aging Population: A Perspective of Pathogenesis and Treatment

Sameer P Leley et al. Clin Interv Aging. .

Abstract

The elderly population in the United States is projected to almost double by the year 2050. In addition, the numbers of diabetics are rising, along with its most common complication, diabetic retinopathy (DR). To effectively treat DR within the elderly population, it is essential first to consider the retinal changes that occur due to aging, such as decreased blood flow, retinal thinning, and microglial changes, and understand that these changes can render the retina more vulnerable to oxidative and ischemic damage. Given these considerations, as well as the pathogenesis of DR, specific pathways could play a heightened role in DR progression in elderly patients, such as the polyol pathway and the vascular endothelial growth factor (VEGF) axis. Current ocular treatments include intravitreal corticosteroids, intravitreal anti-VEGF agents, laser photocoagulation and surgical interventions, in addition to better control of underlying diabetes with an expanding range of systemic treatments. While using therapeutics, it is also essential to consider how pharmacokinetics and pharmacodynamics change with aging; oral drug absorption can decrease, and ocular drug metabolism might affect the dosing and delivery methods. Also, elderly patients may more likely be nonadherent to their medication regimen or appointments than younger patients, and undertreatment with anti-VEGF drugs often leads to suboptimal outcomes. With a rising number of elderly DR patients, understanding how aging affects disease progression, pharmacological metabolism, and adherence are crucial to ensuring that this population receives adequate care.

Keywords: adherence; aging; diabetic retinopathy; pharmacodynamic; pharmacokinetic; vascular endothelial growth factor.

PubMed Disclaimer

Conflict of interest statement

Thomas A Ciulla is an employee and equity holder of Clearside Biomedical, Inc and Ashay D Bhatwadekar is an ad hoc pharmacist at PCA Pharmacy. The authors report no other conflicts of interest in this work.

Figures

Figure 1
Figure 1
Interconnected pathways of DR and areas of susceptibility for the elderly.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14(2):88–98. doi:10.1038/nrendo.2017.151 - DOI - PubMed
    1. Halaweish I, Alam HB. Changing demographics of the american population. Surg Clin North Am. 2015;95(1):1–10. doi:10.1016/j.suc.2014.09.002 - DOI - PubMed
    1. Lee KMC, Sum WMR. Prevalence of diabetic retinopathy in patients with recently diagnosed diabetes mellitus. Clin Exp Optom. 2011;94(4):371–375. doi:10.1111/j.1444-0938.2010.00574.x - DOI - PubMed
    1. Hendrick AM, Gibson MV, Kulshreshtha A. Diabetic retinopathy. Prim Care. 2015;42(3):451–464. doi:10.1016/j.pop.2015.05.005 - DOI - PubMed
    1. Cohen SR, Gardner TW. Diabetic retinopathy and diabetic macular edema. Dev Ophthalmol. 2015;55:137–146. doi:10.1159/000438970 - DOI - PMC - PubMed